Differential control of Eg5-dependent centrosome separation by Plk1 and Cdk1 by Smith, Ewan et al.
EMBO
open
Differential control of Eg5-dependent centrosome
separation by Plk1 and Cdk1
This is an open-access article distributed under the terms of the Creative Commons Attribution Noncommercial Share
Alike 3.0 Unported License, which allows readers to alter, transform, or build upon the article and then distribute the
resultingworkunderthesameorsimilarlicensetothisone.Theworkmustbeattributedbacktotheoriginalauthorand
commercialuse is not permitted without speciﬁcpermission.
Ewan Smith
1, Nadia He ´garat
1,
Clare Vesely
1, Isaac Roseboom
2,
Chris Larch
3, Hansjo ¨rg Streicher
3,
Kornelis Straatman
4, Helen Flynn
5,
Mark Skehel
5, Toru Hirota
6, Ryoko
Kuriyama
7 and Helfrid Hochegger
1,*
1Genome Damage and Stability Centre, University of Sussex, Brighton,
UK,
2Department of Physics and Astronomy, University of Sussex,
Brigthon, UK,
3Department of Chemistry and Biochemistry, University
of Sussex, Brighton, UK,
4Department of Biochemistry, University of
Leicester, Leicester, UK,
5CRUK London Research Institutes Clare Hall,
South Mimms, UK,
6The Cancer Institute, Japanese Foundation for
Cancer Research, Ariake, Tokyo, Japan and
7Department of Genetics,
Cell Biology and Development, University of Minnesota, Minneapolis,
MN, USA
Cyclin-dependent kinase 1 (Cdk1) is thought to trigger
centrosome separation in late G2 phase by phosphorylat-
ing the motor protein Eg5 at Thr927. However, the precise
control mechanism of centrosome separation remains to
be understood. Here, we report that in G2 phase polo-like
kinase 1 (Plk1) can trigger centrosome separation inde-
pendently of Cdk1. We ﬁnd that Plk1 is required for both
C-Nap1 displacement and for Eg5 localization on the
centrosome. Moreover, Cdk2 compensates for Cdk1, and
phosphorylates Eg5 at Thr927. Nevertheless, Plk1-driven
centrosome separation is slow and staggering, while Cdk1
triggers fast movement of the centrosomes. We ﬁnd that
actin-dependent Eg5-opposing forces slow down separation
in G2 phase. Strikingly, actin depolymerization, as well
as destabilization of interphase microtubules (MTs), is
sufﬁcient to remove this obstruction and to speed up
Plk1-dependent separation. Conversely, MT stabilization
in mitosis slows down Cdk1-dependent centrosome move-
ment. Our ﬁndings implicate the modulation of MT stabi-
lity in G2 and M phase as a regulatory element in the
control of centrosome separation.
The EMBO Journal (2011) 30, 2233–2245. doi:10.1038/
emboj.2011.120; Published online 26 April 2011
Subject Categories: cell & tissue architecture; cell cycle
Keywords: actin; Eg5; microtubules; mitosis; Polo kinase
Introduction
Centrosomes are microtubule (MT)-nucleating centres in
animal cells that need to be duplicated during each S phase
and are separated during the G2/M transition to form the
poles of the mitotic spindle (Blagden and Glover, 2003;
Rosenblatt, 2005). Centrosome separation is a complex and
poorly understood process that is of pivotal importance for
chromosome stability. Inaccuracies in the control of centro-
some separation can cause mono- and multipolar mitotic
spindles and could be the cause of genomic instability
(Ganem et al, 2009) and cancer (Basto et al, 2008;
Castellanos et al, 2008). Separation is initiated by disjunction
of the cohesive structures that link the two centriole pairs
(Bornens et al, 1987; Paintrand et al, 1992). The distantly
related proteins Rootletin and C-Nap1 appear to constitute
the molecular core of this structure (Fry et al, 1998; Mayor
et al, 2000; Bahe et al, 2005). Loss of cohesion is thought to
involve Nek2 kinase (Fry et al, 1998), which has recently
been shown to be targeted by the Hippo pathway (Mardin
et al, 2010). Following disjunction, centrosomes are pushed
apart by the force of MT-dependent motor proteins.
This occurs at the very beginning of M phase at about the
time of nuclear envelope breakdown (NEBD). The plus-end-
directed MT motor Eg5 is clearly essential for centrosome
separation across species (Le Guellec et al, 1991; Hagan and
Yanagida, 1992; Hoyt et al, 1992; Roof et al, 1992; Sawin et al,
1992; Heck et al, 1993). Various obstructions have been
reported to impede Eg5 activity (Mountain et al, 1999;
Tanenbaum et al, 2008; Woodcock et al, 2010) and centro-
somes in interphase cells are also subjected to forces that
ensure positioning of the organelle in the cell centre (Burakov
et al, 2003; Zhu et al, 2010). How centrosome disjunction,
separation and positioning are coordinated at the G2/M
transition to allow timely formation of the spindle poles
remains to be determined.
Centrosome separation is under stringent control by mitotic
kinases, such as cyclin-dependent kinase 1 (Cdk1), polo-like
kinase 1 (Plk1), Aurora A and Nek2, but it remains to be shown
in detail how these kinases contribute to this process. Cdk1
has been attributed a central role in controlling centrosome
dynamics (Meraldi and Nigg, 2002; Lim et al, 2009). It is
unclear, if Cdk1 contributes to disjunction, but Cdk1 is thought
to trigger separation by activating Eg5 (Blangy et al, 1995).
Cdk1 phosphorylates Eg5 in its C-terminal tail domain at Thr927
stimulating its binding to MTs (Blangy et al, 1995; Cahu et al,
2008). Conversely, several recent studies suggest that Cdk1
may not be essential for centrosome separation (McCleland
and O’Farrell, 2008; Gavet and Pines, 2010). Thus, Cdk1
function in centrosome separation remains to be ﬁrmly
established.
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2233Plk1 is another mitotic kinase that has been implicated in
regulating bipolar spindle formation (Petronczki et al, 2008).
Polo kinase was originally discovered as a Drosophila
mutant with defective centrosomes and monopolar spindles
(Sunkel and Glover, 1988). Plk1 contributes to accumulation
of g-tubulin at the centrosomes (Lane and Nigg, 1996;
Casenghi et al, 2003; Oshimori et al, 2006) and stabilization
of stable MT-kinetochore attachments (Sumara et al, 2004).
Using Plk1 inhibitors or siRNA-mediated depletion results in
collapsed spindles, with centrosomes in close proximity at
the spindle equator (Sumara et al, 2004; van Vugt et al, 2004;
McInnes et al, 2006; Lenart et al, 2007). However, a direct role
for Plk1 in centrosome disjunction and/or separation remains
to be established. In this study, we aimed to investigate the
role of Cdk1 and Plk1 in triggering centrosome separation.
Results
Centrosome separation occurs in Cdk1-inhibited cells
and depends on Plk1 and Eg5 activity
To clarify the role of Cdk1 in centrosome separation, we took
advantage of a cdk1as DT40 cell line that carries an analogue-
sensitive mutation in Cdk1 (cdk1as cells). In these cells, the
mutant Cdk1 can be inhibited with high speciﬁcity by addi-
tion of the bulky ATP analogue, 1NMPP1, resulting in a late
G2 phase arrest (Figure 1C), while the ATP analogue has
no effect on the cell cycle of cells expressing WT Cdk1
(Hochegger et al, 2007). We found that, despite Cdk1 inhibi-
tion, centrosomes were clearly separated in about 60% of the
1NMPP1-treated cdk1as cells (Figure 1A and B). To conﬁrm
this result in a different experimental system, we used a
chemical Cdk1 inhibitor, RO3306 (Vassilev et al, 2006), in
HeLa cells, and found that approximately half of the RO3306-
treated, G2-arrested cells (Figure 1F) displayed widely sepa-
rated centrosomes (Figure 1D and E). To compare the timing
of centrosome separation in the absence or presence of Cdk1
activity in more detail, we analysed centrosome separation in
cdk1as cells that were pre-synchronized in G1 by elutriation
and progressed to G2/M phase in the presence or absence of
Cdk1 inhibition by 1NMPP1. Supplementary Figure S1A
shows that centrosomes separated while cells progressed
into G2/M. However, separation was delayed by approxi-
mately 2h in the 1NMPP1-treated cells. We conclude from
these results that Cdk1 is not strictly essential for centrosome
separation, but is required for timely initiation of the process.
Next, we investigated the requirement of Plk1 in Cdk1-
independent centrosome separation. We inhibited Plk1 using
the BI2536 compound (Lenart et al, 2007) in combination
with Cdk1 in DT40 and HeLa cells. Plk1 inhibition blocked
centrosome separation in both chicken (Figure 1A and B) and
human cells (Figure 1D and E). We analysed the centrioles in
the BI2536/1NMPP1-treated cdk1as cells by transmission
electron microscopy to rule out that Plk1 inhibition blocks
centrosome replication in S phase. We could readily detect
four centrioles in random sections in the Plk1-inhibited
samples (Supplementary Figure S1B), suggesting that in
these cells, centrioles had replicated, but centrosomes failed
to separate. We also performed a parallel experiment in non-
transformed human RPE cells expressing analogue-sensitive
Plk1 (Burkard et al, 2007) to conﬁrm that the inhibition of
centrosome separation is a speciﬁc effect of Plk1 inhibition.
Cdk1 inhibition by RO3306 blocked cells in both G1 and G2
phases, possibly due to a more central role of Cdk1 in S-phase
progression in these cells. We marked late S/G2 cells by
immuno-ﬂuorescence using CENP-F antibodies (Varis et al,
2006) and scored these cells for separated centrosomes.
G2-arrested Plk1WT-RPE cells treated with the ATP analogue
3MBPP1 displayed separated centrosomes in 90% of G2 cells,
while the same treatment drastically reduced separation in
Plk1as-RPE cells (Supplementary Figure S1C). These
data suggest that Plk1 is required for Cdk1-independent
centrosome separation in G2 phase.
To test the involvement of the motor protein Eg5 in Cdk1-
independent centrosome separation, we used an improved
monastrol derivate Trans24 (Sunder-Plassmann et al, 2005)
to inhibit Eg5 in 1NMPP1-treated cdk1as cells, or the Eg5
inhibitor STLC (DeBonis et al, 2004) in the RO3306-treated
HeLa cells. Strikingly, inhibition of Eg5 resulted in a
drastic reduction of centrosome separation in G2-arrested
DT40 (Figure 1A and B) and HeLa (Figure 1D and E) cells.
Moreover, the distance between the few centrosomes that
managed to separate was markedly decreased after both Plk1
and Eg5 inhibition (Figure 1B and E). Thus, by using different
means of Cdk1, Plk1 and Eg5 inhibition, we found that Plk1
and Eg5 are required for Cdk1-independent centrosome
separation in G2 phase in both chicken and human cells.
Cdk1 and Plk1 trigger centrosome separation
independently, but with different dynamics
Current models of centrosome separation attribute a key role
to Cdk1. Having established that Plk1 and Eg5 initiate cen-
trosome separation independently of Cdk1, we wanted to
address the effect of mitotic Cdk1 activation on the dynamics
of both disjunction and separation. To address the differential
impact of Cdk1 and Plk1 on centrosome separation, we
compared the dynamics of centrosome separation following
the activation of either Plk1 or Cdk1 using a series
of synchronization and release experiments as described in
Figure 2A. Brieﬂy, we synchronized cdk1as cells in G2 phase
with unseparated centrosomes by inhibiting both Cdk1 and
Plk1 kinases. We subsequently removed either inhibitors or
both together from the medium and followed centrosome
separation over time by immuno-ﬂuorescence. We found that
release from the 1NMPP1 arrest in cdk1as cells was more
effective and reproducible than the release from RO3306
(90% versus 20% of mitotic cells after 30min of release;
Xu et al, 2010) and thus decided to perform our analysis in the
DT40 system. Remarkably, activation of both Cdk1 and Plk1
led to a burst of centrosome separation in the ﬁrst 20min
after release in 490% of the cells. These cells readily entered
mitosis and divided within an hour after release (Figure 2B;
Supplementary Figure S2). The initial separation was still
effective even in the presence of the Plk1 inhibitor. However,
in these cells, the mitotic spindles were defective and cells
remained arrested in mitosis (Supplementary Figure S2). The
poles of the mitotic spindle appeared to collapse, having
markedly decreased levels of g-tubulin (compare enlarged
g-tubulin panels in Supplementary Figure S2). In marked
contrast, Plk1-driven centrosome separation was ineffective
and slow, reaching an average distance of 4mm after 3h
(Figure 2B; Supplementary Figure S2).
In order to observe the dynamics of disjunction and
separation in single cells, we performed a parallel experiment
using 3D live cell imaging of GFP-g-tubulin-expressing cdk1as
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striking difference between centrosome separation triggered
by Plk1 and Cdk1. If Cdk1 remained inactive, centrosome
disjunction occurred on average an hour after release from
BI2536 (Figure 3A and B; Supplement Movie S2). Moreover,
movement of the centrosomes was not linear, but pulling and
pushing forces appeared to compete with each other. We
determined an average centrosome velocity of 0.04mm/min
in these cells. Activation of Cdk1 caused a dramatic change in
dynamics of both disjunction and movement. The centro-
somes came apart within minutes and had undergone con-
siderable separation within the ﬁrst 5min after release
(Figure 3A and B; Supplement Movie S1). The initial
dynamics of Cdk1-driven centrosome separation were only
modestly changed in the presence of the Plk1 inhibitor.
Disjunction occurred with a brief delay at about 5min after
release, and the average velocity of separation was decreased
from 1.1mm/min when both Plk1 and Cdk1 were active to
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Figure 1 Cdk1-independent centrosome separation requires Plk1 and Eg5 activity. (A) DT40 cdk1as cells were analysed by immuno-
ﬂuorescence using anti-g-tubulin and anti-centrin-2 antibodies and counterstained with DAPI. The panels display deconvolved maximum
intensity projections (MIPs) of 3D images of representative samples (scale bar, 5mm). Asynchronous cells are shown in the far left panel (As.).
Cdk1 was inhibited by treating cells for 6h with 10mM 1NMPP1 (1NM). To inhibit Plk1, 100nM of BI 2536 was added at the same time as
1NMPP1 (1NMþBI). To inhibit chicken Eg5, we added 33mM trans-24 together with 1NMPP1 (1NMþTrans). (B) Quantitative analysis of
centrosome separation using immuno-ﬂuorescence and automated scanning microscope analysis (Olympus SCAN-R; see Material and
methods). As., N¼962; 1NM, N¼1300; 1NMþBI, N¼569; 1NMþTrans, N¼638; error bars indicate the s.d. in three independent
experiments. We scored centrosome distances in the same samples by analysing 3D images using IMARIS (N¼50); distances above 0.5mm
were scored as separated; results from individual cells are plotted; the bars show the mean distances (As., 3.4mm; 1NM, 5.25mm; 1NMþBI,
1.8mm; 1NMþTrans, 1.84mm). (C) PI staining and FACS analysis of same samples as in (A). (D) HeLa cells were analysed by immuno-
ﬂuorescence using anti-g-tubulin, anti-pericentrin antibodies and DAPI. The panels display deconvolved MIPs of 3D images of representative
samples (scale bar, 10mM). Asynchronous cells are shown in the far left panel (As.). Cdk1 was inhibited by treating cells for 20h with 7.5mM
RO3306 (RO). To inhibit Plk1, 100nM of BI 2536 was added at the same time as RO 3066 (ROþBI). To inhibit human Eg5, we added 5mM STLC
together with RO3306 (ROþSTLC). (E) Quantitative analysis of 3D images (% separation As., N¼524; RO, N¼343; ROþBI,
N¼415; ROþSTLC, N¼380; error bars indicate the s.d. in three independent experiments). Distances were scored in 3D images using
Imaris (N¼50) as in (B); the bars indicate the mean distance; As., 5.7mm; RO, 9.2mm; ROþBI, 4.6mm; ROþSTLC, 4.1mm. (F) FACS analysis
of the indicated HeLa samples.
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observations in Figure 2, Plk1 inhibition caused a dispersal
of GFP-g-tubulin from the centrosomes after NEBD and it
became progressively harder to detect the GFP signal on the
spindle poles (Figure 3A; Supplement Movie S3).
In summary, these data suggest that both Cdk1 and Plk1
are able to trigger centrosome separation, albeit with very
different dynamics. Several questions arise from these
observations. First, the role of Plk1 in centrosome separation
needs to be clariﬁed. Plk1 could act at the disjunction step,
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Figure 3 Dynamics of Plk1 and Cdk1 induced centrosome separation in live cells. (A) 3D time-lapse microscopy of differentially released
cdk1as cells expressing GFP-g-tubulin (see Materials and methods). The still images are MIPs of deconvolved 3D images (scale bar, 5mm) from
a time-lapse series (see also Supplementary Movies 01–03). (B) Quantiﬁcation of centrosome distance for each release experiment. Distances
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Disjunction was deﬁned as the ﬁrst time point at which a distance of 41mm was reached. Velocities were calculated as described in Materials
and methods.
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the difference in the speed of separation needs to be
explained. In the absence of Cdk1 activity mutually opposing
forces appear to act on the centrosome, resulting in a
staggering to-and-fro movement. Once Cdk1 is active, centro-
somes move rapidly and without apparent hindrance. This
could be explained by the full activation of Eg5 by Cdk1,
which could be sufﬁcient to overcome the resistant force.
Alternatively, Eg5 may already be fully primed for action in
interphase and mitotic Cdk1 may act by down-regulating the
Eg5-opposing forces. In this case, experimental elimination of
these forces should be sufﬁcient to speed up the process even
in the absence of Cdk1 activity.
Plk1 acts both upstream and downstream of C-Nap1
displacement from the centrosomes
We ﬁrst investigated the role of Plk1 in centrosome disjunc-
tion. This process is initially triggered by loss of cohesive
proteins that hold the duplicated centriole pairs together.
C-Nap1 has been reported to form the core of this structure
and depletion of this protein is sufﬁcient to trigger centro-
some splitting (Mayor et al, 2000; Bahe et al, 2005). We
reasoned that if Plk1 acts upstream of C-Nap1 displacement,
this protein should still be present on the centrosomes when
both Cdk1 and Plk1 are inhibited. Conversely, inhibition of
Cdk1 alone should result in displacement of C-Nap1 from the
centrosomes. Figure 4A shows that C-Nap1 is not detectable
on centrosomes in RO3306-treated HeLa cells, while it is
localized at centrosomes in cells treated with both Cdk1
and Plk1 inhibitors. Previous studies reported a decrease in
C-Nap1 levels in mitotic cells (Mayor et al, 2002). It was
reported that this reduction is not due to proteasome-depen-
dent degradation of C-Nap1 but may be a consequence
of mitotic-speciﬁc phosphorylation. We found that C-Nap1
levels were signiﬁcantly reduced in Cdk1-inhibited cells
compared with an asynchronous control (Figure 4B).
However, Plk1 inhibition did not alter this reduction of
C-Nap1 levels. These results suggest that while Plk1 acts
speciﬁcally on the displacement of C-Nap1 from the centro-
somes, the changes in total protein levels occur in G2 phase
independently of both Plk1 and Cdk1.
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be sufﬁcient to explain why centrosome separation is blocked
by Plk1 inhibition. If this were true, artiﬁcial destruction of
centrosome cohesion by C-Nap1 depletion should be sufﬁ-
cient to allow centrosome separation in the absence of Plk1
activity. We tested this hypothesis by knocking down C-Nap1
in cells treated with both the RO3306 and BI2536 inhibitors.
Our siRNAs successfully depleted C-Nap1 as judged by
immuno-blots and immuno-ﬂuorescence (Figure 4C and D).
However, C-Nap1 depletion did not trigger centrosome
separation in the Plk1-inhibited cells (Figure 4E), suggesting
additional requirements for Plk1 in the separation mechan-
ism following disjunction.
Interphase Cdks and Plk1 collaborate to trigger
centrosome localization of Eg5 in G2 phase
We next investigated how Cdks and Plk1 regulate Eg5 in G2
and M phase. A key event in the initiation of centrosome
separation is the phosphorylation of Eg5 in its C-terminal
tail domain at Thr927 stimulating its binding to MTs and
localization at the mitotic spindle (Blangy et al, 1995;
Sawin and Mitchison, 1995; Cahu et al, 2008). Mitotic Cdk1
is thought to be responsible for this phosphorylation.
However, we observed that Eg5 mediates centrosome separa-
tion independently of Cdk1. This prompted us to probe
the phosphorylation of Eg5 after Cdk1 inhibition using
a P-Thr927 phospho-speciﬁc antibody (Materials and meth-
ods). We conﬁrmed that this antibody only cross-reacted with
phosphorylated Eg5 (Supplementary Figure S3A and B) and
used it to compare Eg5 phosphorylation in Cdk1-inhibited
and mitotic cells (DT40 cdk1as cells in Figure 5A; HeLa cells
in Supplementary Figure S3C). Surprisingly, we found that
the majority of Eg5 was already phosphorylated at Thr927
despite Cdk1 inhibition in both human and chicken cells.
There was no major increase in phosphorylation in the
released mitotic cells, but phosphorylation levels dropped
signiﬁcantly as cells progressed into G1 phase (Figure 5A).
Plk1 inhibition had no effect on Eg5 phosphorylation at
Thr927 (Figure 5B) suggesting that the kinase is not involved
in this control pathway.
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phosphorylate Eg5 on Thr927 in G2 phase. Accordingly, we
conﬁrmed that recombinant Cdk2/cyclin A phosphorylates
Eg5 on Thr927 in vitro (Figure 5C). Moreover, further inhibi-
tion of both Cdk1 and Cdk2 by Roscovitine signiﬁcantly
reduced Thr927 phosphorylation in Cdk1-inhibited DT40
and HeLa cells (Figure 5D; Supplementary Figure S3D). We
further probed the involvement of Cdk2 in Eg5 Thr927
phosphorylation by using a cdk1as/cdk2 double mutant cell
line (Hochegger et al, 2007). When treated with 10mM
1NMPP1, these cells arrest in both G1 and G2 phases due
to the requirement of Cdk1 in S-phase progression in the
absence of Cdk2 (Supplementary Figure S3E). Under these
circumstances, Eg5 Thr927 phosphorylation is abolished
(Figure 5E), but this could be a secondary effect of the earlier
cell-cycle arrest. A lower dose of 1NMPP1 allows enough Cdk
activity for S-phase progression, but is still sufﬁcient to block
the mitotic functions of Cdk1 resulting in a G2 arrest
(Supplementary Figure S3E). This dose of 1NMPP1 is also
permissive for Thr927 phosphorylation (Figure 5E). However,
a further shift to 10mM 1NMPP1 in these G2-arrested cells
causes a signiﬁcant decrease in Thr927 phosphorylation
(Figure 5E), while the same dose does not block Eg5 phos-
phorylation in G2 phase when Cdk2 is present (Figure 5A).
Thus, either Cdk1 or Cdk2 can phosphorylate Eg5 at Thr927
in interphase.
To test what effect Cdk and Plk1 inhibition has on Eg5
localization, we probed Hela cells by immuno-ﬂuorescence
using Eg5 antibodies (Figure 5F). In Cdk1-inhibited cells, Eg5
is strongly enriched on centrosomes. When either Cdk2 or
Plk1 activity is further inhibited in these cells, this centroso-
mal localization is lost, and at the same time centrosome
maturation appears to be reversed as judged by decreased
intensity of the signal from the anti-Pericentrin antibody.
Thus, interphase Cdks and Plk1 cooperate to load Eg5 on
the centrosomes prior to mitotic entry. However, Cdk1 could
still further contribute to Eg5 activation via phosphorylation
on sites other than Thr927. We searched for such novel sites
in Eg5 by mass spectrometry (MS) analysis, but only detected
the Thr927 phosphorylation event in Eg5 puriﬁed from either
mitotic or G2-arrested cdk1as cells (Table I).
Depolymerization of the actin cytoskeleton inhibits the
Eg5-opposing forces and increases the speed of
centrosome separation in Cdk1-inhibited cells
Our analysis of Eg5 regulation suggests that this motor
protein is already primed for action in G2 phase and may
not be further activated by mitotic Cdk1. We thus shifted our
attention to the Eg5-opposing forces that appear to hinder
centrosome separation in G2 phase. First, we hypothesized
that inactivation of Eg5 by inhibition of Plk1 or Cdk2 may
shift the balance in favour for these opposing forces and
cause already separated centrosomes to be pushed back
together. We could detect such a reverse movement of
centrosomes by live cell imaging (Figure 6A–C) and in cells
ﬁxed prior and post Plk1 or Cdk2 inhibition (Figure 6D;
Supplementary Figure S3E). We hypothesized that the source
of this Eg5-opposing activity could be related to the centro-
some positioning forces that pull the centrosomes to the
centre of interphase cells. An elegant model implies that
this force is exerted via long and stable MTs that emanate
from the centrosome and reach the actin cytoskeleton at the
cell cortex (Burakov et al, 2003; Zhu et al, 2010). Thus, we
tested the involvement of the actin polymers in force genera-
tion in our centrosome separation assay. For this purpose, we
inhibited actin polymerization concomitantly with either Plk1
or Cdk activity in G2-arrested cdk1as cells and probed for
reversal of centrosome separation. Strikingly, cytochalasin D,
a potent inhibitor of actin polymerization, effectively abol-
ished the reversal of centrosome separation under these
circumstances (Figure 6D). This reverse force was also de-
pendent on stable MTs and was inhibited by low doses
of Nocodazole. Conversely, centrosomes were still pushed
together after inhibition of Myosin 2 by Blebbistatin
(Figure 6D).
Having found a way to inhibit the forces that reverse
centrosome separation, we tested if we could speed up the
dynamics of Plk1-dependent centrosome separation simply
by relieving the centrosomes from this obstruction. We
performed a similar block release experiment as described
in Figure 2A, synchronizing the cells with unseparated cen-
trosomes in G2 phase by Cdk1 and Plk1 inhibition. When we
removed the Plk1 inhibitor from the medium, we could detect
hardly any increase in centrosome separation in the ﬁrst hour
(Figures 2B and 6E). In marked contrast, the majority of
centrosomes were widely separated within an hour in the
presence of cytochalasin D. This separation was still depen-
dent on Eg5 and was reversed by addition of Eg5 inhibitors
(Figure 6E). Taken together, these data suggest that Eg5 is
already primed for fast centrosome separation in G2 phase
prior Cdk1 activation, but kept in check by forces that act on
the centrosome via stable interphase MTs and depend on a
stable actin cytoskeleton.
Increased dynamic instability of mitotic MTs is a
regulatory element in the control of centrosome
separation
It has long been known that MT dynamic instability is
dramatically increased as cells enter mitosis (Wittmann
et al, 2001), and Cdk1 has been shown to up-regulate MT
dynamics in a number of model systems (Lamb et al, 1990;
Verde et al, 1992; Moutinho-Pereira et al, 2009). Thus, the
loss of long astral MTs following Cdk1 activation could
contribute to the rapid and efﬁcient centrosome separation
Table I Analysis of Eg5 by mass spectrometry
Number of
peptides
Coverage
(%)
Modiﬁcation
ETD
1NM 22 18 Thr927
1NM/BI 23 22 Thr927
Rel 28 24 Thr927
CID
1NM 50 44 Thr924/927
1NM/BI 52 46 Thr927
Rel 64 65 Thr927
Analysis of post-translational modiﬁcation of Eg5 puriﬁed by large-
scale immuno-precipitation from cdk1as cells collected after 6h
treatment with 10mM 1NMPP1 (1NM), 10mM 1NMPP1 and 100nM
BI2536 (1NM/BI) and 30min after release from a 6-h arrest in 10mM
1NMPP1 (Rel). Samples were analysed as described in Materials
and methods. Electron transfer dissociation (ETD) and collision-
induced dissociation (CID) were used for sample detection.
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To test this hypothesis, we ﬁrst conﬁrmed that changes in MT
dynamics occur following cdk1 activation in cdk1as cells.
We probed cdk1as cells for MT nucleation activity before and
after Cdk1 activation by depolymerizing MTs with high
Nocodazole doses and observing MT repolymerization fol-
lowing removal of Nocodazole. Figure 7A shows that Cdk1-
arrested (Cdk1off) cells displayed long astral MTs that
reached from the centrosome to the cell periphery. In cells
released from Cdk1 inhibition (Cdk1on), only very short MTs
nucleated at the centrosomes. If this change in MT stability
has indeed a role in the control of centrosome separation,
we should see reduced separation in M phase but not G2
following MT stabilization; the opposite should be the case
for MT destabilization, which should speed up separation in
G2, but not in M phase. We tested this hypothesis by
measuring distances of separated centrosomes after treat-
ment with low doses of Nocodazole and Taxol. Figure 7B
and C shows that MT stabilization with Taxol did indeed
result in decreased separation in M but not G2 phase, while
destabilization of MTs in a low Nocodazole dose did cause an
increase in separation in G2-arrested cells but had little effect
on M-phase cells.
Discussion
Our data suggest that centrosome separation is subjected to a
complex interplay of controls and is already initiated in G2
phase by Plk1 and interphase Cdks, while being greatly
enhanced by mitotic Cdk1 (see model in Figure 7). In agree-
ment with previous studies (McCleland and O’Farrell, 2008;
Gavet and Pines, 2010), we ﬁnd that Cdk1 is not essential to
allow the centrosomes to come apart in G2 phase before
NEBD. We ﬁnd that Plk1 activity is required for C-Nap1
displacement from the centrosomes in G2 phase, and that
this disjunction step is slow and inefﬁcient. Cdk1 activation
signiﬁcantly changes the timing of disjunction, with centro-
somes coming apart within minutes of kinase activation
independently of Plk1. Mardin et al (2010) recently reported
a novel mechanism of centrosome disjunction that involves
the regulation of Nek2 and C-Nap1 by Mst2 kinase. This
pathway appeared to be only required when centrosome
separation was slowed down by partial Eg5 inhibition. It is
tempting to speculate that Plk1 could be linked to the Mst2-
dependent pathway, while Cdk1 activation could cause an
increase in the force of separation that is per se sufﬁcient to
quickly break the cohesion between the centrosomes.
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Figure 6 Plk1 inhibition results in reversal of centrosome separation in G2 phase. (A) Experimental set-up of Plk1 shut-off experiment. DT40
cdk1as cells are blocked in G2 with separated centrosomes by 6h 10mM 1NMPP1 treatment. At this time, 100nM BI2536 was added to the cells
and distances of centrosomes were scored by live cell imaging of GFP-g-tubulin. (B) Quantitative analysis of time-lapse microscopy of BI2536-
treated and control cells. Centrosome distances were measured in 20 cells every 20min using Imaris 3D analysis tools. (C) 3D time-lapse
microscopy of BI2536-treated and control cells expressing GFP g-tubulin. The still images are MIPs of deconvolved 3D images (scale bar, 2mm)
from the time-lapse series (see also Supplementary Movies 04 and 05). (D) Centrosome collapse assay in ﬁxed cdk1as cells probed by immuno-
ﬂuorescence with g-tubulin antibodies. Cells were treated for 6h with 0.5mM 1NMPP1 and for the last hour additionally 50mM Roscovitine or
100nM BI2536 (6hþRos and 6hþBI). In further samples, 10mM CytochalasinD (CytoD), 50mM Blebbistatin (Bleb) or 20ng/ml Nocodazole
(Noc) were added in parallel to the Plk1 and Cdk inhibitors. Mean centrosome distance was measured three times (N4100 in each experiment)
using Imaris. The images shown are MIPs from 3D stack images. (E) Dynamics of centrosome separation were assayed in a release experiment
as described in Figure 2. cdk1as cells were treated for 6h in 10mM 1NMPP1 and 100nM BI2536. Subsequently, BI2536 was washed out and
centrosome separation was assayed at the indicated time points by g-tubulin immuno-ﬂuorescence. Following release from Plk1 inhibition,
cells were treated with either DMSO (control), 10mM cytochalasinD (CytoD) or 33mM Trans24 (Trans). Centrosome separation was counted
in three independent experiments using Imaris. The pictures shown are MIPS of 3D stack images.
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centrosomes apart both before and after Cdk1 activation,
albeit with greatly different dynamics. Both Plk1 and inter-
phase Cdk1/2 activity contributes to Eg5 enrichment at the
centrosome. Cdk1/2 regulate this step via Thr927 phosphor-
ylation, which stimulates MT binding (Cahu et al, 2008). Plk1
does not appear to phosphorylate Eg5 in vitro (Hochegger
Laboratory, unpublished results), and Plk1 inhibition does
not appear to affect the phosphorylation of Eg5 at Thr927 but
controls accumulation of pericentriolar material in G2 phase
in concert with interphase Cdks (Figure 5F). However,
a functional correlation between centrosome maturation
and Eg5 recruitment has yet to be established. In principle,
Eg5 should move towards the plus end of the MTs and it
remains to be clariﬁed how Eg5 is actually retained and
concentrated at the minus end of MTs at the centrosome.
We did not ﬁnd any evidence that Cdk1 further modiﬁes Eg5
and accordingly Blangy et al (1995) showed that Thr927 was
the only Cdk phosphorylation site in the protein. However,
we cannot exclude that Cdk1 also exerts additional control on
Eg5 in M phase.
The dramatic increase in the velocity of centrosome
separation after Cdk1 activation may thus be a result, not
of Eg5 activation, but of the removal of the force that opposes
separation. This obstruction of separation becomes apparent
when either Cdks or Plk1 is inhibited in G2 phase, most likely
because of the inactivation of Eg5. Conversely, Eg5 inhibition
in mitosis does not result in spindle pole collapse in mitotic
cells (Kapoor et al, 2000). The minus-end-directed motor
protein Dynein (Tanenbaum et al, 2008; Ferenz et al, 2009)
as well as the Tiam1, Rac signalling pathway (Woodcock
et al, 2010) have been implicated in this force generation.
Interestingly, Dynein has also been proposed to generate
force on the long astral interphase MTs that connect
the centrosome to the cell cortex (Burakov et al, 2003;
Zhu et al, 2010). These forces are thought to ensure the
positioning of the centrosome in the cell centre. In this
study, we provide evidence that actin polymers as well as
stable MTs are required to generate the force that reverses
centrosome separation in G2 phase. Myosin does not appear
to be involved in force generation, but the actin cytoskeleton
may simply serve as a matrix that MT-dependent motors use
to push or pull on the centrosome. The Dynein/Dynactin
complex that cross-links MTs to actin is a likely candidate to
generate this force by providing a balanced pulling force from
all directions. Force could also be generated by a kinesin
pushing towards the plus end, or simply from MT polymer-
ization as demonstrated in vitro (Holy et al, 1997).
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Figure 7 Dynamics of centrosome separation in G2 and M phase depend on MTstability. (A) MT nucleation assay in G2 and M phase cdk1as
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by forces coming from radial MT that connect to the cell cortex. The force is generated by cortical dynein (pulling force), and/or an unknown
kinesin (pushing force). In G2 phase, Cdk2 and Plk1 trigger Eg5 enrichment at the centrosome. Plk1 also triggers centrosome disjunction via
C-Nap1 displacement. However, the Eg5 obstructing forces still prevail and delay separation. Cdk1 activation triggers an increase in MT
depolymerization, thereby releasing the centrosome from the Eg5 counteracting forces and allowing Eg5 to push the centrosomes rapidly apart.
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struction to centrosome separation by depolymerizing the
actin cytoskeleton, to considerably increase the efﬁciency
of Plk1-dependent centrosome separation in G2 phase
(Figure 6). This result suggests that Eg5 is ready for action
prior to Cdk1 activation, but kept in check by the opposing
force. It is thus likely that Cdk1 triggers fast separation by
breaking the Eg5-opposing force. Our results in Figure 7
suggest that destabilization of the long interphase MTs by
Cdk1 has a critical role in this step. However, Cdk1 could also
contribute to modulation of Dynein motor activity and to
rearrangements in the actin cytoskeleton.
The question remains why such a differentially controlled
mechanism for centrosome separation has evolved. Gavet
and Pines (2010) have shown in a series of elegant experiments
that in an unperturbed cell cycle, centrosome separation
coincides with Cdk1 activation. However, manipulation of
cell-cycle progression by synchronization led to uncoupling
of Cdk1 activity and centrosome separation. Plk1-triggered
centrosome separation may thus only become apparent when
cell-cycle progression has been delayed. Such a delay may,
for example, occur in response to DNA damage, or other
obstacles to cell-cycle progression. Under these circum-
stances, it could be desirable to prepare the cells for mitotic
entry even in the absence of Cdk1 activity by triggering
centrosome separation. It is noteworthy that Plk1 also pro-
vides alternative mechanisms for loss of chromosome cohe-
sion (Alexandru et al, 2001) and centriole disengagement
(Tsou et al, 2009). In both cases, Plk1 acts in parallel with
Separase to provide an independent way of achieving loss of
cohesion between sister chromatids and centrioles. Thus, a
function for Plk1 to control back-up pathways appears to be a
common theme during mitosis. Our results suggest that such
a function also exists in regulating centrosome separation.
Materials and methods
Chemicals and biochemicals
All chemicals were obtained from Fisher Scientiﬁc or Sigma-Aldrich
unless otherwise stated. 1NMPP1 was synthesized following
published procedures (Bishop et al, 1999). 3MBPP1 was a kind
gift from Prasad Jallepalli (Memorial Sloan-Kettering Cancer Center,
New York, USA). Recombinant Cdk1/cyclinA was a kind gift from
Tim Hunt (Clare Hall Laboratories, London, UK) Protease and
phosphatase inhibitor (Phos-stop) cocktails were from Roche
Diagnostics, West Sussex, UK. Protein G Dynabeads and ProLong
s
Gold with DAPI were purchased from Invitrogen Ltd, Paisley, UK.
Bio-Rad protein assay reagent was obtained from Bio-Rad Labora-
tories Ltd, Hertfordshire, UK. RO3306 and MG132 were purchased
from Merck Chemicals Ltd, Nottingham, UK. BI2536 was purchased
from Axon Medchem. Trans24 was bought from Axxora Ltd,
Nottingham, UK. Plasmids expressing GST-Eg5 was a gift from Ann
Blangy and Frank Kozielski.
Cell culture, synchronization and inhibitor treatments
Chicken DT40 cells including cdk1as cells were cultured as
previously described (Hochegger et al, 2007). For Cdk1 inhibition,
cells were treated with 10mM 1NMPP1 for 6h; in the case of GFP-
g-tubulin-expressing cells, this was extended to 8h to compensate
for slower growth of these cells (data not shown). To inhibit Plk1,
100nM BI2536 was added to the media for 6h. To inhibit Eg5,
33mM Trans24 was added to media for 6h. For release experiments,
cells were then rinsed with 3  50ml RPMI media containing
indicated drugs and cultured further for indicated time points.
To obtain mitotic DT40 cells, cells were collected after 30min of
release and for G1 cells, 90min after release. Mitotic enrichment
for immuno-precipitation experiments was performed by adding
0.1mg/ml Nocodazole to cells for 4h. Elutriation of DT40 cells was
performed as described previously (Takata et al, 1998).
HeLa cells were cultured in Dulbecco’s modiﬁed Eagle Medium
supplemented with 10% FCS, 2mM L-glutamine, 100U/ml peni-
cillin and 0.1mg/ml streptomycin in a 371C, 5% CO2 incubator.
To inhibit Cdk1 activity, cells were treated with 7.5mM RO3306 to
10 mM for 20h. We found signiﬁcant batch-to-batch variation in the
effect of RO3306, with some batches causing a G1 arrest at 10mM; in
these cases, we reduced the dose to 7.5mM to obtain a G2 arrest.
To inhibit Plk1, 100nM BI2536 was added to the media for 20h and
for Eg5 inhibition 100nM STLC was added to media for 20h. For
roscovitine treatments, DT40 cells were treated with 10mM 1NMPP1
for 6h followed by 2h with the addition of 50mM roscovitine. For
roscovitine treatments, HeLa cells were treated with 7.5mM RO3306
for 20h followed by 4h with the addition of 50mM roscovitine.
Plk1WT-RPE or Plk1as-RPE cells were a kind gift of Prasad
Jallepalli and cultivated as described (Burkard et al, 2007). To
inhibit Cdk1 in this cell line, 5mM RO3306 was added to the media
and to inhibit the Plk1as mutant 20mM 3MBPP1 was added for 20h.
Antibodies
Primary antibodies used for this study were generally bought from
Abcam and were used at manufacturers’ recommended concentra-
tions. Centrin-2 rabbit polyclonal was a gift from Elmar Schiebel;
Alexa-ﬂuor
s-conjugated secondary antibodies for immunostaining
or FACS analysis; Alexa488 anti-rabbit, Alexa488 anti-mouse and
Alexa594 anti-rabbit were purchased from Invitrogen and HRP-
conjugated rabbit or mouse polyclonal secondary antibodies for
western blotting were from Dakocytomation Ltd, Cambridge, UK.
Immuno-ﬂuorescence, microscopy and image analysis
Hela and RPE cells were grown on coverslips and ﬁxed for 10min in
3.7% formaldehyde, rinsed 4  in PBS and ﬁxed in methanol
for 10min at  201C. DT40 cell suspension cultures (B5 10
4 cells
per 0.1ml) were spun onto slides at 1000r.p.m. for 3min using a
cell spin cytocentrigfuge from Tharmac. Cells were then ﬁxed using
3.7% formaldehyde for 10min. Slides or coverslips were then rinsed
in PBS and cells permeabilized in PBS-0.1% NP40. Cells were
blocked in 1% BSA for 30min and probed with primary antibodies
(as indicated in ﬁgure legends) for 30min–1h. Slides/coverslips
were rinsed 4  in PBS and probed with Alexa secondary antibodies
listed below for 30min to 1h. Slides/coverslips were then rinsed
4  in PBS and coverslips were mounted using ProLong
s Gold
mounting solution containing DAPI (Invitrogen). For standard image
acquisition, a personal Delta Vision
s microscope equipped with a
UPLS apo, N.A. 1.4,  100 oil immersion objective (Olympus),
standard ﬁlter sets (excitation 360/40; 490/20; 555/28; emission 457/
50; 528/38; 617/40) and a Cascade EMCCD camera (Roper scientiﬁc).
Z-series of 0.3mm stacks were acquired using SoftWorx software
(Version 3.7.1) and deconvolution performed using SVI Huygens
Professional Deconvolution Software (Version 3.5). Maximum in-
tensity projections were obtained in Omero (Version Beta 4.1.1) and
exported as Tiff ﬁles. For centrosome separation and distance
analysis, images were acquired on the Delta Vision
s microscope
with  100 or  60 (PlAPON, 1.42 NA) oil immersion objective as
described above. Delta Vision ﬁles were imported into Imaris software
(Bitplane, Version 6.3.0) for 3D distance measurements. Measure-
ments were then exported to Excel and plotted.
Where indicated, an Olympus Scan-R (Version 2.1) automated
image acquisition microscope with  40 oil immersion objective
(UPLFLN, N.A. 1.3) was used to acquire images and to quantify and
analyse the number of g-tubulin spots (centrosomes) per nuclei
(DAPI) using the ScanR
s analysis software. We set up the analysis
so that pairs of centrosomes with distances 40.5mm were scored
as separated. Image gating and edge detection was performed
according to the manufacturers’ protocols.
Live cell imaging
Cdk1as cells were stably transfected with GFP g-tubulin in an
IresPuroexpression vector (a gift from Toru Hirota, Cancer Centre,
Tokyo). Note that these cells already express GFP (Hochegger et al,
2007), so that both the entire cell, as well as the centrosomes can be
visualized. Time-lapse microscopy was performed on concavalin-
coated coverglass chambers (Nunc) in CO2-independent medium
(Invitrogen) in an environmental chamber heated to 391C using
a personal DeltaVision
s microscope and a  100 oil immersion
objective as described above with GFPO ﬁlters (excitation 470/40;
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either 30s, or 2min intervals using 1%, or 10% neutral density
ﬁlters and  100 gain on the EMCCD camera. The 3D time series
was deconvolved using Huygens Professional Deconvolution soft-
ware and analysed in Imaris. Maximum intensity projections of the
time series were exported into Quicktime format for presentation as
Supplementary Movies. For velocity calculations, we calculated
the ratio of the distance travelled in each time step and the length of
each time step. We only included data for distances above 2mm
to focus on separation dynamics after successful disjunction. The
mean of the instantaneous separation velocities was calculated for
each run, and the mean and s.d. of the data from ﬁve runs are
shown.
Preparation of total cell extracts, immuno-blotting,
immuno-precipitation, phosphatase treatments and
in vitro phosphorylation assays
For cell lysate preparation, 10
6 DT40 cells or 1–5 10
5 HeLa or RPE
cells were washed once in PBS and lysed in 50ml ECB buffer (50mM
Tris pH 7.5, 120mM NaCl, 0.5% NP40, 1mM EDTA, 0.05%
b-mercaptoethanol and protease (1 tablet/50ml) and phosphatase
(1 tablet per 10ml) inhibitors), incubated on ice for 20min. Cells
were sonicated, cell debris was then cleared by centrifugation at
13000r.p.m., 10min at 41C and the supernatants were transferred
to fresh tubes. Protein concentrations were determined by Bradford
method and lysates were equalized for protein concentration using
ECB buffer. For immuno-precipitation, cells were lysed in 500mlI P
lysis buffer (20mM Tris pH 7.5, 137mM NaCl, 10% glycerol, 1%
triton, 2mM EDTA, 0.05% b-mercaptoethanol, protease and
phosphatase inhibitors (as above)). Lysates were sonicated, cleared
and equalized as above. Lysates were incubated with 3–5mg Myc or
Eg5 antibody (as indicated in ﬁgure legends) at 41C for 1h with end
over end rotation and 20ml of Protein G Dynabeads
s were added to
precipitated proteins. Samples were incubated at 41C for a further
2h. Beads were then rinsed with 3  1ml IP lysis buffer. Beads were
then re-suspended in 1  SDS–PAGE sample buffer (12.5mM Tris–
HCl pH 6.8, 1.4% (w/v) SDS, 4% sucrose (w/v), 0.002% (w/v)
bromophenyl blue, 0.4mM b-mercaptoethanol) or prepared for
kinase assays or phosphatase treatment. For Eg5 kinase assays,
immuno-precipitates were washed once in 1ml kinase assay buffer
(50mM MOPS, pH 7.5, 5mM MgCl2, 0.4mM EGTA, 2mM EDTA and
protease/phosphatase tablets (as described above)). Beads were
then re-suspended in 20ml kinase assay buffer. To each reaction,
0.2mg/ml bacterially expressed recombinant GST-Eg5 was added,
and to start reactions, 10mlo f1 0 0mM ATP (made up in kinase assay
buffer) was added. Reactions were incubated at 371C for 20min and
were terminated with the addition of 15ml5   SDS–PAGE sample
buffer and boiling at 951C for 5min. In vitro kinase assays using
recombinant CDK2/cyclinA at 40ng/ml with 0.2mg/ml GST-Eg5 were
started by adding 25mM ATP. Reactions were incubated at 371C
for 20min and were terminated with the addition of 15ml5  
SDS–PAGE sample buffer and boiling at 951C for 5min. For
phosphatase treatments, cells were lysed in phosphatase inhibitor-
free IP lysis buffer, immuno-precipitated proteins were then rinsed
twice in 500ml phosphatase buffer (50mM HEPES, pH 7.5, 100mM
NaCl, 2mM DTT, 0.01% Brij-35 and 1mM MnCl2) and re-suspended
in 20ml phosphatase buffer. To one tube, 1ml of calf immune
alkaline phosphatase (Sigma) was added and reactions incubated at
301C for 1h. Reactions were stopped by the addition of SDS–PAGE
sample buffer and boiling at 951C for 5min. Samples were then
analysed by western blotting.
SiRNA transfections
HeLa cells were seeded in six-well plates at a density of
0.4 10
5cells/ml and 24h later were transfected with 20nM control
siRNA for human GAPDH 3 (FlexiTube siRNA (Qiagen) target
sequence: AAGGTCGGAGTCAACGGATTT) or 20nM C-NAP1 mix
(FlexiTube siRNA target sequences: CACGGTCGCCTTCTCAGTCTA,
CAGCTTCGACTGCACATGGAA), using HiPerFect transfection
reagent (Qiagen) following the manufacturers’ protocol; 30h later
cells were treated with 10mM RO3306 (Cdk1) and 100nM BI2536
(Plk1) inhibitors, where indicated. Cells were then prepared for
immuno-ﬂuorescence or western blotting as described.
Large-scale immuno-precipitation for MS
A total of 5 10
8 DT40 cdk1as cells were treated for 6h with 10mM
1NMPP1 (to inhibit CDK1) with or without 100nM BI2536 (Plk1
inhibitor). For mitotic extracts, 1NMPP1 blocked cells were then
released as described in the release protocol for 30min. Cell pellets
were then rinsed in PBS and re-suspended in IP lysis buffer. Lysates
were sonicated, cleared and then equalized by Bradford method. In
all, 1ml batches of lysates were incubated with 5mg of Eg5 antibody
at 41C and immuno-precipitation performed as above. Beads were
pooled and re-suspended in 70ml NuPAGE 1  sample buffer
(Invitrogen) containing reducing agent. Samples were subjected
to electrophoresis on 4–12% Bis–Tris minigels (Invitrogen), with
MOPs running buffer. Gels were ﬁxed and stained with colloidal
blue stain (Invitrogen) as per manufacturers’ protocol. Eg5 bands
(as judged from parallel western blot analysis) were excised and
prepared for tryptic digestion and MS.
Mass spectrometry
Gel slices (1–2mm) were prepared for mass spectrometric analysis
using the Janus liquid handling system (Perkin-Elmer, UK).
Gel pieces were destained with 50% v/v acetonitrile and 50mM
ammonium bicarbonate, reduced with 10mM DTT and alkylated
with 55mM iodoacetamide. After alkylation, proteins were digested
with 6ng/ml Trypsin (Promega, UK) overnight at 371C. Peptides
were extracted in 2% v/v formic acid and 2% v/v acetonitrile. The
digest was analysed by nano-scale capillary LC–MS/MS using
a nanoAcquity UPLC (Waters, UK). A C18 symmetry 5mm,
180mm 20mm m-Precolumn (Waters, UK), trapped the peptides
prior to separation on a C18 BEH130 1.7mm, 75mm 100 mm
analytical UPLC column (Waters, UK). Peptides were eluted with a
gradient of acetonitrile. The analytical column outlet was directly
interfaced via a modiﬁed nano-ﬂow electrospray ionization source,
with a hybrid linear quadrupole Fourier transform mass spectro-
meter (LTQ Orbitrap XL/ETD, ThermoScientiﬁc, San Jose). Data-
dependent analysis was carried out using a resolution of 30000 for
the full MS spectrum, followed by eight MS/MS spectra in the linear
ion trap. LC–MS/MS data were then searched against a protein
database (UniProt KB) using the Mascot search engine programme
(Matrix Science, UK) allowing for variable modiﬁcations including
phosphorylated residues. MS/MS data were validated using the
Scaffold programme (Proteome Software Inc.).
FACS analysis
Cells were trypsinized, spun down, washed once with PBS and
then ﬁxed using 70% EtOH. Cells were centrifuged at 1500r.p.m. for
3min and rinsed in 0.5ml of 3% BSA solution, re-centrifuged and
re-suspended in 0.5ml 3% BSA solution containing 1mg/ml RNAse
A and 5mg/ml propidium iodide. Cells were then analysed for DNA
content using an FACSCanto (BD Biosciences) and FACS Diva
software to plot PI area versus cell counts.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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